[HTML][HTML] Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium
Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
[HTML][HTML] SARS-CoV-2, COVID-19 and the aging immune system
JM Bartleson, D Radenkovic, AJ Covarrubias… - Nature aging, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a global health threat with
particular risk for severe disease and death in older adults and in adults with age-related …
particular risk for severe disease and death in older adults and in adults with age-related …
[HTML][HTML] Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study
I Katsoularis, O Fonseca-Rodríguez, P Farrington… - The Lancet, 2021 - thelancet.com
Background COVID-19 is a complex disease targeting many organs. Previous studies
highlight COVID-19 as a probable risk factor for acute cardiovascular complications. We …
highlight COVID-19 as a probable risk factor for acute cardiovascular complications. We …
[HTML][HTML] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
[HTML][HTML] Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis
Background Studies have suggested that there is increased risk of thromboembolism (TE)
associated with coronavirus disease 2019 (COVID-19). However, overall arterial and …
associated with coronavirus disease 2019 (COVID-19). However, overall arterial and …
The impact of COVID-19 disease on platelets and coagulation
GD Wool, JL Miller - Pathobiology, 2021 - karger.com
Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …
patients develop a severe proinflammatory state which can be associated with a unique …
Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis
Background The association of pulmonary embolism (PE) with deep vein thrombosis (DVT)
in patients with coronavirus disease 2019 (COVID-19) remains unclear, and the diagnostic …
in patients with coronavirus disease 2019 (COVID-19) remains unclear, and the diagnostic …
Global incidence of neurological manifestations among patients hospitalized with COVID-19—a report for the GCS-NeuroCOVID consortium and the ENERGY …
Importance The COVID-19 pandemic continues to affect millions of people globally, with
increasing reports of neurological manifestations but limited data on their incidence and …
increasing reports of neurological manifestations but limited data on their incidence and …
Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
Background Individual studies have reported widely variable rates for VTE and bleeding
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …
[PDF][PDF] Effects of COVID-19 on the nervous system
Neurological complications have emerged as a significant cause of morbidity and mortality
in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized …
in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized …